But if new market entrants aren't able to submit an application and get it through the FDA, then guess what? You have, in this case, Mylan, who is able to market a product, quickly raise the price, bring home an exorbitant amount of profit, with no competition.
Buck discusses the lack of competition in the pharmaceutical market leading to high prices.
Share
More from Ken Buck
Moscow Marjorie is focused now on this Ukraine issue and getting her talking points from the Kremlin.
Well, I think it's part of President Trump's theater or certainly his style, to make a lot of bold claims. And then some of them he will act on, and some of them he will back off of.
I think Mike Johnson's on the right side of history. And I think that Republicans and Democrats will rally around someone who is showing leadership on Capitol Hill.
I do think that Rudy Giuliani and others knew what they did was wrong.
Other voices in this conversation
